Cargando…

Staphylococcus lugdunensis Endophthalmitis Following Intravitreal Anti-vascular Endothelial Growth Factor Injections

Staphylococcus lugdunensis is a rare causative organism of endophthalmitis following intravitreal injections. It presents an aggressive disease course with potentially devastating outcomes. In this case, the patient presented late with a severely painful, red eye with a reduced visual acuity from 6/...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Umar, Nozad, Lava, Saldana-Velez, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Ophthalmology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671385/ https://www.ncbi.nlm.nih.gov/pubmed/36407209 http://dx.doi.org/10.7759/cureus.30439

Ejemplares similares

Staphylococcus lugdunensis endophthalmitis following dexamethasone intravitreal implant
por: Salceanu, Silvia Olivia, et al.
Publicado: (2019)

Endophthalmitis After Intravitreal Bevacizumab (Avastin) Injections: An Outbreak Investigated
por: Shoaib, Khawaja K, et al.
Publicado: (2023)

Incidence of Acute Endophthalmitis After Intravitreal Bevacizumab Injection at a Tertiary Care Hospital in Lahore
por: Ahmed, Nasir, et al.
Publicado: (2021)

Batch-related sterile endophthalmitis following intravitreal injection of bevacizumab
por: Entezari, Morteza, et al.
Publicado: (2014)

Acute-onset endophthalmitis caused by Staphylococcus lugdunensis
por: Garoon, Robert B., et al.
Publicado: (2017)

Post-intravitreal injection endophthalmitis pattern during the COVID-19 pandemic with implementation of patients’ masking
por: Mirghorbani, Masoud, et al.
Publicado: (2022)

Staphylococcus lugdunensis Endophthalmitis: Case Series and Literature Review
por: Chen, Kuan-Jen, et al.
Publicado: (2022)

Anterior Chamber Paracentesis Offers a Less Painful Experience During Intravitreal Anti-vascular Endothelial Growth Factor Administration: An Intraindividual Study
por: Karakahya, Refika Hande
Publicado: (2021)

Non-immediate drug hypersensitivity reactions secondary to intravitreal anti-vascular endothelial growth factors
por: Moret, E., et al.
Publicado: (2021)

Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents
por: Labardini, Cecilia P., et al.
Publicado: (2018)

Intravitreal Anti-vascular Endothelial Growth Factor (Anti-VEGF) Therapy for Valsalva Related Sub-internal Limiting Membrane (Sub-ILM) Macular Haemorrhage: A Case Report
por: Nur-Najwa, Suhaifi, et al.
Publicado: (2023)

Intravitreal Injection-Induced Migraine Headaches
por: Lerebours, Valerie C, et al.
Publicado: (2016)

Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review
por: Merani, Rohan, et al.
Publicado: (2015)

Incidence of Endophthalmitis after Intravitreal Anti-Vascular Endothelial Growth Factor Injections in an Operating Room in China
por: Chen, Yanyun, et al.
Publicado: (2020)

Nutritionally variant streptococci causing endophthalmitis associated with intravitreal anti-vascular endothelial growth factor injection
por: Steinmetz, Robert L., et al.
Publicado: (2021)

Refractive outcomes after intravitreal injection of antivascular endothelial growth factor versus laser photocoagulation for retinopathy of prematurity: a meta-analysis
por: Kong, Qihang, et al.
Publicado: (2021)

The Impact of Physician Face Mask Use on Endophthalmitis After Intravitreal Anti–Vascular Endothelial Growth Factor Injections
por: Patel, Samir N., et al.
Publicado: (2021)

Response of Pediatric Choroidal Neovascularization to Anti-Vascular Endothelial Growth Factor
por: Ruparelia, Sunil, et al.
Publicado: (2021)

The Influence of Universal Face Mask Use on Endophthalmitis Risk after Intravitreal Anti–Vascular Endothelial Growth Factor Injections
por: Patel, Samir N., et al.
Publicado: (2021)

Management of Accidental Intravitreal Dexamethasone Injection Into the Lens: A Case Report
por: Siotto Pintor, Emanuele, et al.
Publicado: (2023)

Prevalence and Visual Consequences of Non-adherent Patients Receiving Anti-vascular Endothelial Growth Factor (VEGF) Injections at King Fahad Specialist Hospital (KFSH), Qassim Region
por: Alharbi, Abdulmajeed D, et al.
Publicado: (2023)

Submacular Hemorrhage Following Aflibercept Intravitreal Injection: A Report of Two Cases
por: Khoo, Chloe, et al.
Publicado: (2022)

The Risk of Non-arteritic Ischemic Optic Neuropathy Post-intravitreal Bevacizumab Injection
por: Fugara, Nasser A, et al.
Publicado: (2022)

Immediate Rise in Intraocular Pressure After First-Time Intravitreal Injection of Bevacizumab
por: Mahar, Pir S, et al.
Publicado: (2023)

Endophthalmitis diagnosis supported by bedside ultrasound
por: Gong, Jing Jing, et al.
Publicado: (2022)

Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis
por: Pham, Ba', et al.
Publicado: (2019)

Acceptability of intravitreal injections in geographic atrophy: protocol for a mixed-methods pilot study
por: Enoch, Jamie, et al.
Publicado: (2021)

Incidence of Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor: Experience in Saudi Arabia
por: Al-Rashaed, Saba, et al.
Publicado: (2016)

Trends, geographical variation and factors associated with the use of anti-VEGF intravitreal injections in Portugal (2013–2018): a retrospective analysis of administrative data
por: Rocha, João Victor, et al.
Publicado: (2022)

Postoperative Endophthalmitis After Cataract Surgery: An Update
por: Althiabi, Saad, et al.
Publicado: (2022)

Neonatal Endogenous Endophthalmitis: A Case Report
por: Alhamoud, Mustafa A, et al.
Publicado: (2022)

Full-Thickness Macular Hole After Intravitreal Conbercept Injection in Branch Retinal Vein Occlusion
por: Xie, Pinxue, et al.
Publicado: (2023)

Intravitreal injections with anti-VEGF agent aflibercept versus subthreshold micropulse laser for chronic central serous chorioretinopathy: the alternative treatment regimens for verteporfin-shortage in China
por: Zhao, Tantai, et al.
Publicado: (2023)

Review of Studies Comparing Panretinal Photocoagulation and Anti-Vascular Endothelial Growth Factor Therapy in the Treatment of Proliferative Diabetic Retinopathy
por: Gunasekaran, Thiruvarasu, et al.
Publicado: (2022)

Endophthalmitis After Cataract Surgery: A Postoperative Complication
por: Wadbudhe, Akshad M, et al.
Publicado: (2022)

Pain related to intravitreal injections for age-related macular degeneration: a qualitative study of the perspectives of patients and practitioners
por: Yiallouridou, Christina, et al.
Publicado: (2023)

Case Study of Endogenous Streptococcal Endophthalmitis in the Critical Care Setting
por: Reddy, Akshay J, et al.
Publicado: (2021)

Acute-Onset Postoperative Herpetic Endophthalmitis: A Case Report
por: Gupta, Vinita, et al.
Publicado: (2023)

Sterile Endophthalmitis after Intravitreal Injections
por: Marticorena, Joaquín, et al.
Publicado: (2012)

Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections
por: Lau, P. ET., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0du1pgn7vgs3k7g2vlc49f3piv